RxDoctor Payments Data

Latoya Jackson

Psychiatric/Mental Health · Coral Springs, FLNPI 1538512017

Payments from drug & device makers

$643in general payments, 2019–2025

Across 13 payments — averaging $49.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$126
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$125
  • Livanova USA, Inc.$112
  • Johnson & Johnson$92
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$49
  • AbbVie$40
  • plus $98 from 4 others

What the payments were for

  • Food & beverage$643100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$643 in reported general payments places this provider in the 45th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$4,244
Medicare patients
20
Services billed
54

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lurasidone Hcl15$11,402
Quetiapine Fumarate22$833
Buspirone Hcl36$491
Lamotrigine35$299
Risperidone19$280
Escitalopram Oxalate18$223
Duloxetine Hcl17$197
Fluoxetine Hcl24$184
Aripiprazole17$174
Memantine Hcl13$143
Bupropion XlBupropion Hcl14$131
Sertraline Hcl20$125
Hydroxyzine Pamoate12$114
Zolpidem Tartrate16$102
Clonazepam11$78

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Coral Springs

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →